Origin of circulating free DNA in patients with lung cancer.

by Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, Shinya Kimura, Atsushi Kawaguchi, Naoko Sueoka-Aragane
Published 2020-01-01

Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer

by Kazutoshi Komiya, Tomomi Nakamura, Tomonori Abe, Shinsuke Ogusu, Chiho Nakashima, Koichiro Takahashi, Shinya Kimura, Naoko Sueoka‐Aragane
Published 2019-09-01